These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7562295)

  • 1. Hypertrophy of the tongue associated with inhaled corticosteroid therapy in premature infants.
    Linder N; Kuint J; German B; Lubin D; Loewenthal R
    J Pediatr; 1995 Oct; 127(4):651-3. PubMed ID: 7562295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bronchopulmonary dysplasia. Retrospective analysis of various forms of treatment and development of a staged therapeutic plan].
    Bauer J; Beedgen B; Böhler T; Sontheimer D; Zilow EP; Linderkamp O
    Klin Padiatr; 1996; 208(2):56-60. PubMed ID: 8901183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticosteroids in the prevention and management of bronchopulmonary dysplasia.
    Grier DG; Halliday HL
    Semin Neonatol; 2003 Feb; 8(1):83-91. PubMed ID: 12667833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of inhaled glucocorticosteroids and recovery from adrenal suppression after systemic steroid use in a VLBW premature infant with BPD: case report and literature discussion.
    Karinski DA; Balkundi D; Rubin LP; Padbury JF
    Neonatal Netw; 2000 Dec; 19(8):27-32. PubMed ID: 11949271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postnatal corticosteroids for preterm infants--do what we say, not what we do.
    Jobe AH
    N Engl J Med; 2004 Mar; 350(13):1349-51. PubMed ID: 15044647
    [No Abstract]   [Full Text] [Related]  

  • 6. [Bronchopulmonary dysplasia and corticosteroid therapy].
    Chérif A; Marrakchi Z; Chaouachi S; Boukef S; Sfar R
    Arch Pediatr; 2002 Feb; 9(2):159-68. PubMed ID: 11915499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence-based neonatal pharmacotherapy: postnatal corticosteroids.
    Watterberg K
    Clin Perinatol; 2012 Mar; 39(1):47-59. PubMed ID: 22341536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia - Who might benefit?
    Doyle LW; Cheong JLY
    Semin Fetal Neonatal Med; 2017 Oct; 22(5):290-295. PubMed ID: 28734731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The use of postnatal corticosteroid therapy in premature infants to prevent or treat bronchopulmonary dysplasia: current situation and recommendations].
    Jarreau PH; Fayon M; Baud O; Autret-Leca E; Danan M; de Verdelhan A; Castot A
    Arch Pediatr; 2010 Oct; 17(10):1480-7. PubMed ID: 20864322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meter-dosed, inhaled beclomethasone attenuates bronchoalveolar oxyradical inflammation in premature infants at risk for bronchopulmonary dysplasia.
    Zimmerman JJ; Gabbert D; Shivpuri C; Kayata S; Ciesielski W; Miller J; Peters ME; Eissenstat RP; Shen G
    Am J Perinatol; 1998; 15(10):567-76. PubMed ID: 9926878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled corticosteroids and children.
    Baraldi E; Filippone M
    N Engl J Med; 2006 Aug; 355(6):625; author reply 625-6. PubMed ID: 16903019
    [No Abstract]   [Full Text] [Related]  

  • 12. Are postnatal steroids ever justified to treat severe bronchopulmonary dysplasia?
    Eichenwald EC; Stark AR
    Arch Dis Child Fetal Neonatal Ed; 2007 Sep; 92(5):F334-7. PubMed ID: 17712183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia.
    Ng PC
    Arch Dis Child; 1993 Mar; 68(3 Spec No):330-6. PubMed ID: 8466274
    [No Abstract]   [Full Text] [Related]  

  • 14. The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia.
    Williams AF
    Arch Dis Child; 1993 Sep; 69(3 Spec No):331. PubMed ID: 8215580
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhaled and systemic steroid exposure and neurodevelopmental outcome of preterm neonates.
    Kelly EN; Shah VS; Levenbach J; Vincer M; DaSilva O; Shah PS;
    J Matern Fetal Neonatal Med; 2018 Oct; 31(20):2665-2672. PubMed ID: 28714339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertrophic obstructive cardiomyopathy as a side effect of dexamethasone treatment for bronchopulmonary dysplasia.
    Brand PL; van Lingen RA; Brus F; Talsma MD; Elzenga NJ
    Acta Paediatr; 1993; 82(6-7):614-7. PubMed ID: 8339005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Corticosteroid therapy for the prophylaxis of bronchopulmonary dysplasia in kids with very low body weight].
    Tsvetkova S; Chernookova V
    Akush Ginekol (Sofiia); 2002; 41 Suppl 2():21-3. PubMed ID: 19708190
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of dexamethasone in premature infants at risk for bronchopulmonary dysplasia or who already have developed chronic lung disease: a cautionary note.
    Frank L
    Pediatrics; 1991 Aug; 88(2):413-6. PubMed ID: 1741827
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhaled versus systemic steroids in chronic oxygen dependency of preterm infants.
    Dimitriou G; Greenough A; Giffin FJ; Kavadia V
    Eur J Pediatr; 1997 Jan; 156(1):51-5. PubMed ID: 9007492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexamethasone in the treatment of bronchopulmonary dysplasia.
    Benini F; Rubaltelli FF; Griffith P; Sala M; Zorzi C
    Acta Paediatr Scand Suppl; 1989; 360():108-12. PubMed ID: 2642245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.